After 14 and 21 days, mRNA levels of DMP1, DSPP, and OCN were upregulated in the MBNs-NH2–treated cells to a greater extent than in the OM-treated control cells (Fig 5C and 5D, p<0.05). The gene discussed is BGLAP; the disease is ocular melanoma.